Supplements for Melasma: Tranexamic Acid, Vitamin…

Melasma is a chronic, recurring hyperpigmentation disorder characterized by irregular brown or grayish patches on sun-exposed areas, most commonly the face. It disproportionately affects women and people with darker skin tones, and is driven by a complex interaction of UV radiation, hormonal influences (estrogen and progesterone), and inflammatory signals that chronically overstimulate melanocytes. Topical treatments—hydroquinone, retinoids, azelaic acid—remain the standard of care, but oral supplements have emerged as meaningful adjuncts that address the systemic drivers topicals cannot reach.

Oral Tranexamic Acid

Tranexamic acid (TXA) is an anti-fibrinolytic compound that has unexpectedly become one of the most effective oral treatments for melasma. TXA blocks plasminogen from binding to keratinocytes, which interrupts the UV-induced release of arachidonic acid and prostaglandins that stimulate melanocyte activity. This breaks a key signaling loop in melasma pathogenesis. A landmark 2016 Korean study found that oral TXA at 250 mg twice daily for 12 weeks significantly reduced MASI scores (Melasma Area and Severity Index) compared to placebo. Multiple subsequent studies have confirmed efficacy at 250–500 mg/day, with results appearing at 4–8 weeks. Oral TXA is prescription in some countries and over-the-counter in others—consult a dermatologist for guidance. Side effects are rare at these doses but include mild gastrointestinal discomfort; TXA should be avoided in those with clotting disorders or thrombosis risk.

Vitamin C (Ascorbic Acid)

Vitamin C inhibits melanin synthesis through two mechanisms: it directly inhibits tyrosinase (the key enzyme in melanin production) and it reduces oxidized melanin intermediates, preventing them from polymerizing into the dark pigment deposits seen in melasma. Oral vitamin C at 500–1,000 mg/day provides a systemic tyrosinase-inhibiting effect that complements topical brightening agents. Additionally, vitamin C is essential for collagen synthesis—maintaining a healthy epidermal-dermal junction reduces the inflammatory signals that perpetuate melanocyte stimulation. Studies have found that oral vitamin C combined with vitamin E produces synergistic photoprotection that reduces the UV triggering of new melasma lesions.

Glutathione

Oral glutathione has become widely used for skin brightening and melasma in Asian markets, where it is available in oral, sublingual, and intravenous forms. Mechanistically, glutathione shifts melanogenesis from eumelanin (dark brown/black pigment) to phaeomelanin (lighter yellow/red pigment) by inhibiting tyrosinase and suppressing the melanogenic pathway. A 2014 randomized, double-blind, placebo-controlled trial found that 500 mg/day of oral glutathione for 4 weeks significantly reduced skin melanin index across multiple facial and non-facial sites. Reduced L-glutathione (the standard supplement form) is absorbed, though some researchers advocate for liposomal glutathione or S-acetyl glutathione for enhanced intracellular delivery.

Polypodium Leucotomos

UV radiation is the most consistent trigger for melasma exacerbation. Polypodium leucotomos extract (PL) reduces the UV-induced inflammatory cascade that stimulates melanocytes, and has been specifically studied for melasma. A 2004 randomized controlled trial found that PL (4 capsules of 240 mg extract twice daily) significantly reduced melasma severity at 12 weeks compared to placebo. The mechanism involves PL's inhibition of UV-induced reactive oxygen species and its suppression of NF-kB, reducing the cytokines that chronically activate melanocytes.

Pycnogenol

Pycnogenol (French maritime pine bark extract) inhibits tyrosinase and has antioxidant properties that reduce UV-triggered melanocyte activation. A 2002 study found that 75 mg/day of Pycnogenol for 30 days reduced melasma pigmentation and significantly improved MASI scores. Its combination of tyrosinase inhibition, antioxidant activity, and vascular protective effects makes it a useful complement to TXA and glutathione.

Practical Protocol

For oral melasma treatment, the strongest evidence supports oral tranexamic acid (under medical supervision) as the primary agent, complemented by vitamin C (500–1,000 mg/day), glutathione (500 mg/day), and Polypodium leucotomos (240–480 mg/day) for UV protection. This should always be combined with strict sun protection (SPF 50+ sunscreen, hats, UV-protective clothing), as UV is the dominant trigger that all the oral treatment in the world cannot compensate for without sun avoidance.

FAQ

How long does oral tranexamic acid take to improve melasma? Most patients see measurable improvement at 4–8 weeks, with optimal results at 12–16 weeks. Long-term maintenance (at lower doses or intermittently) may be needed because melasma recurs when treatment is stopped without maintaining UV protection.

Is oral glutathione safe for long-term use? Glutathione is endogenous to the body and orally consumed glutathione is generally considered safe. Long-term data at 500 mg/day is limited but existing evidence shows no significant adverse effects. Consult a dermatologist for doses above 1,000 mg/day.

Can men use these supplements for melasma? Yes. While melasma affects women more frequently, men can develop it—particularly with high sun exposure and no hormonal trigger. The same supplement protocol applies.

Track your supplements in Optimize.

Supplements for Melasma: Tranexamic Acid, Vitamin C, and Glutathione